Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

J&J’s Spravato touts durable anti-depressant benefits in real-world study

Summary by Clinical Trials Arena
J&J’s Spravato offered durable symptomatic TRD improvements in the Phase IV ECHO study conducted across Europe and Israel.The post J&J’s Spravato touts durable anti-depressant benefits in real-world study appeared first on Clinical Trials Arena.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Clinical Trials ArenaClinical Trials Arena

J&J’s Spravato touts durable anti-depressant benefits in real-world study

J&J’s Spravato offered durable symptomatic TRD improvements in the Phase IV ECHO study conducted across Europe and Israel.The post J&J’s Spravato touts durable anti-depressant benefits in real-world study appeared first on Clinical Trials Arena.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Clinical Trials Arena broke the news in on Monday, March 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Johnson & Johnson icon

Johnson & Johnson

Israel icon

Israel

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal